CoChat

Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression

Ford, Nick, Ludbrook, Guy, Galletly, Cherrie · 2015 · Australian & New Zealand Journal of Psychiatry

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

Integrity signals

Registry

Crossref · 10.1177/0004867415590631

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Cited by

See all 23

Metadata

Authors
Ford, N., Ludbrook, G., & Galletly, C.
Affiliations
The University of Adelaide (AU)
Corresponding author
Galletly, Cherrie
Venue
Australian & New Zealand Journal of Psychiatry
Published
2015-06-09
Volume
49
Issue
12
Pages
1227-1227
ISSN
  • 0004-8674 (ISSN-L)
  • 1440-1614
OpenAlex
W2272012343
Cited by
23
References
3
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2021: 7 · 2020: 4 · 2018: 1 · 2017: 3 · 2016: 2
FWCI
1.45
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Australian & New Zealand Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
benzodiazepines, ketamine, depression, antidepressant efficacy, drug interactions, treatment-resistant depression
MeSH terms
Quetiapine Fumarate, Antidepressive Agents, Benzodiazepines, Bipolar Disorder, Drug Interactions, Drug Therapy, Combination, Fluoxetine, Humans, Ketamine, Lorazepam, Middle Aged, Antipsychotic Agents, Lithium Compounds, Antimanic Agents, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression. https://app.cochat.ai/papers/10.1177/0004867415590631
The paper
Ford, N., Ludbrook, G., & Galletly, C. (2015). Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867415590631

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.